Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats
Identifieur interne : 000323 ( Main/Exploration ); précédent : 000322; suivant : 000324Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats
Auteurs : Sanman Ghorpade [Inde] ; Raakhi Tripathi [Inde] ; Dipesh Sonawane [Inde] ; Neelam Manjrekar [Inde]Source :
- Journal of Basic and Clinical Physiology and Pharmacology [ 0792-6855 ] ; 2011-12-01.
Abstract
Background: Certain unknown aspects of ropinirole action, such as its antidepressant effect after chronic administration and on cotreatment with fluoxetine, remain to be evaluated, which formed the rationale for this study. Methods: Wistar rats of either sex (weighing 150–200 g) were used. In the dose-finding study, oral dose of ropinirole (20 mg/kg) was selected. This was combined with two different doses of fluoxetine (10 and 20 mg/kg). Their antidepressant-like effects were compared in acute and chronic forced-swim test (FST). Acute FST was conducted in two sessions after administration of three doses within 24 h. Chronic FST was conducted over 14 days. Drugs were administered each day for 14 days. Effect on locomotor activity was tested in OFT. Results: ANOVA with post hoc Tukey test was used. Dose-finding study of ropinirole showed that out of three doses, 20 mg/kg produced maximum reduction in immobility in acute FST (137±8 s). Coadministration of ropinirole with fluoxetine in acute FST further reduced immobility (107±8 s). This effect was more prominent in chronic forced-swim-stressed rats (74±2 s). Neither ropinirole nor its coadministration with fluoxetine increased locomotor activity in open-field test. Conclusions: The potential of ropinirole to act as an antidepressant agent is proven by the reduction in immobility time in FST. Further, there is an augmentation of the effect of fluoxetine by ropinirole, suggesting synergistic interaction of dopamine and serotonin pathway in brain.
Url:
DOI: 10.1515/JBCPP.2011.027
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats</title><author><name sortKey="Ghorpade, Sanman" sort="Ghorpade, Sanman" uniqKey="Ghorpade S" first="Sanman" last="Ghorpade">Sanman Ghorpade</name></author><author><name sortKey="Tripathi, Raakhi" sort="Tripathi, Raakhi" uniqKey="Tripathi R" first="Raakhi" last="Tripathi">Raakhi Tripathi</name></author><author><name sortKey="Sonawane, Dipesh" sort="Sonawane, Dipesh" uniqKey="Sonawane D" first="Dipesh" last="Sonawane">Dipesh Sonawane</name></author><author><name sortKey="Manjrekar, Neelam" sort="Manjrekar, Neelam" uniqKey="Manjrekar N" first="Neelam" last="Manjrekar">Neelam Manjrekar</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:171533371B5858EC6FAEAD7F6A8AF55A0582ECA0</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1515/JBCPP.2011.027</idno><idno type="url">https://api.istex.fr/document/171533371B5858EC6FAEAD7F6A8AF55A0582ECA0/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000E37</idno><idno type="wicri:Area/Main/Curation">000C70</idno><idno type="wicri:Area/Main/Exploration">000323</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats</title><author><name sortKey="Ghorpade, Sanman" sort="Ghorpade, Sanman" uniqKey="Ghorpade S" first="Sanman" last="Ghorpade">Sanman Ghorpade</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Glaxosmithkline, Mumbai</wicri:regionArea><wicri:noRegion>Mumbai</wicri:noRegion></affiliation></author><author><name sortKey="Tripathi, Raakhi" sort="Tripathi, Raakhi" uniqKey="Tripathi R" first="Raakhi" last="Tripathi">Raakhi Tripathi</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai</wicri:regionArea><wicri:noRegion>Mumbai</wicri:noRegion></affiliation></author><author><name sortKey="Sonawane, Dipesh" sort="Sonawane, Dipesh" uniqKey="Sonawane D" first="Dipesh" last="Sonawane">Dipesh Sonawane</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai</wicri:regionArea><wicri:noRegion>Mumbai</wicri:noRegion></affiliation></author><author><name sortKey="Manjrekar, Neelam" sort="Manjrekar, Neelam" uniqKey="Manjrekar N" first="Neelam" last="Manjrekar">Neelam Manjrekar</name><affiliation wicri:level="1"><country xml:lang="fr">Inde</country><wicri:regionArea>Department of Pharmacology, TN Medical College and Nair Hospital, Mumbai</wicri:regionArea><wicri:noRegion>Mumbai</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Basic and Clinical Physiology and Pharmacology</title><title level="j" type="abbrev">Journal of Basic and Clinical Physiology and Pharmacology</title><idno type="ISSN">0792-6855</idno><idno type="eISSN">2191-0286</idno><imprint><publisher>Walter de Gruyter</publisher><date type="published" when="2011-12-01">2011-12-01</date><biblScope unit="volume">22</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="109">109</biblScope><biblScope unit="page" to="114">114</biblScope></imprint><idno type="ISSN">0792-6855</idno></series><idno type="istex">171533371B5858EC6FAEAD7F6A8AF55A0582ECA0</idno><idno type="DOI">10.1515/JBCPP.2011.027</idno><idno type="ArticleID">jbcpp.2011.027</idno><idno type="Related-article-Href">jbcpp.2011.027.pdf</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0792-6855</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Certain unknown aspects of ropinirole action, such as its antidepressant effect after chronic administration and on cotreatment with fluoxetine, remain to be evaluated, which formed the rationale for this study. Methods: Wistar rats of either sex (weighing 150–200 g) were used. In the dose-finding study, oral dose of ropinirole (20 mg/kg) was selected. This was combined with two different doses of fluoxetine (10 and 20 mg/kg). Their antidepressant-like effects were compared in acute and chronic forced-swim test (FST). Acute FST was conducted in two sessions after administration of three doses within 24 h. Chronic FST was conducted over 14 days. Drugs were administered each day for 14 days. Effect on locomotor activity was tested in OFT. Results: ANOVA with post hoc Tukey test was used. Dose-finding study of ropinirole showed that out of three doses, 20 mg/kg produced maximum reduction in immobility in acute FST (137±8 s). Coadministration of ropinirole with fluoxetine in acute FST further reduced immobility (107±8 s). This effect was more prominent in chronic forced-swim-stressed rats (74±2 s). Neither ropinirole nor its coadministration with fluoxetine increased locomotor activity in open-field test. Conclusions: The potential of ropinirole to act as an antidepressant agent is proven by the reduction in immobility time in FST. Further, there is an augmentation of the effect of fluoxetine by ropinirole, suggesting synergistic interaction of dopamine and serotonin pathway in brain.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><country name="Inde"><noRegion><name sortKey="Ghorpade, Sanman" sort="Ghorpade, Sanman" uniqKey="Ghorpade S" first="Sanman" last="Ghorpade">Sanman Ghorpade</name></noRegion><name sortKey="Manjrekar, Neelam" sort="Manjrekar, Neelam" uniqKey="Manjrekar N" first="Neelam" last="Manjrekar">Neelam Manjrekar</name><name sortKey="Sonawane, Dipesh" sort="Sonawane, Dipesh" uniqKey="Sonawane D" first="Dipesh" last="Sonawane">Dipesh Sonawane</name><name sortKey="Tripathi, Raakhi" sort="Tripathi, Raakhi" uniqKey="Tripathi R" first="Raakhi" last="Tripathi">Raakhi Tripathi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000323 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000323 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:171533371B5858EC6FAEAD7F6A8AF55A0582ECA0
|texte= Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats
}}
| This area was generated with Dilib version V0.6.23. |  |